| Application no. and date | 17804304.8 (espacenet) (Federated) (European Patent Register), 20171114 | | Patent/reg. no. and date | DK/EP 3541387, 20210421 | | Publication date | 20190925 | | Priority no. and date | US 201662422144 P, 20161115, US 201762479391 P, 20170331 | | EP pub. no. and date |
EP 3541387 20190925 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | BT/GP/164748 | | Inventor | FERRETTI, Stephane, c/o Novartis Pharma AG
Novartis Institutes for BioMedical Research
Klybeckstrasse 141
Postfach
4002 Basel, CH,
GUERREIRO, Nelson, c/o Novartis Pharma AG
Novartis Institutes for BioMedical Research
Fabrikstrasse 2
4056 Basel, CH,
JEAY, Sebastien, c/o Novartis Pharma AG
Werk Klybeck
Postfach
4002 Basel, CH,
JULLION, Astrid, c/o Novartis Pharma AG
Forum 1
4056 Basel, CH,
MEILLE, Christophe, c/o Novartis Pharma AG
Novartis Institutes for BioMedical Research
Fabrikstrasse 2
4056 Basel, CH,
WUERTHNER, Jens, c/o Novartis Pharma AG
Novartis Institutes for BioMedical Research
Postfach
4002 Basel, CH | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/401 (2006.01) , A61K 31/404 (2006.01) , A61K 31/4418 (2006.01) , A61K 31/4439 (2006.01) , A61K 31/47 (2006.01) , A61K 31/496 (2006.01) , A61K 31/506 (2006.01) , A61P 35/00 (2006.01) | | Title | DOSIS OG REGIME FOR HDM2-P53-INTERAKTIONSINHIBITORER | | Int. application no. | IB2017057097 | | Int. publication no. | WO2018092020 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
